Study of SQZ-eAPC-HPV in Patients With HPV16+ Recurrent, Locally Advanced or Metastatic Solid Tumors

NCT05357898 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

TERMINATED

Status

20

Enrollment

INDUSTRY

Sponsor class

Stopped Corporate Decision

Conditions

Adult Solid Tumor

Interventions

BIOLOGICAL: SQZ-eAPC-HPV
BIOLOGICAL: Pembrolizumab

Sponsor

SQZ Biotechnologies